USD 129.71
(-3.5%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 3.94 Billion | 3.94 Billion | 2.89 Billion | 1.33 Billion | 1.64 Billion | 1.93 Billion |
Net Income | 1.38 Billion | 2.57 Billion | 890 Million | -2.83 Billion | -240 Million | -115 Million |
Depreciation & Amortization | 2.19 Billion | 1.7 Billion | 1.52 Billion | 2.07 Billion | 2.12 Billion | 1.88 Billion |
Deferred income taxes | 196 Million | 317 Million | 122 Million | -53 Million | 17 Million | -120 Million |
Stock-based compensation | 87 Million | 83 Million | 77 Million | 79 Million | 85 Million | 72 Million |
Change in working capital | -552 Million | -1.27 Billion | -101 Million | -470 Million | -595 Million | -186 Million |
Other non-cash items | 636 Million | 545 Million | 374 Million | 2.54 Billion | 253 Million | 405 Million |
Investing Cash Flow | -4.66 Billion | -2.55 Billion | -1.32 Billion | -1.7 Billion | -2.84 Billion | -1.56 Billion |
Investments in PPE | -4.1 Billion | -2.72 Billion | -1.74 Billion | -2.19 Billion | -2.82 Billion | -2.09 Billion |
Acquisitions | -547 Million | -332 Million | -237 Million | 232 Million | -331 Million | 396 Million |
Investment purchases | - | - | - | - | -33 Million | -67 Million |
Sales/Maturities of investments | - | - | - | - | 331 Million | - |
Other Investing Activities | -8 Million | 502 Million | 659 Million | 258 Million | 19 Million | 598 Million |
Financing Cash Flow | -77 Million | -1.1 Billion | -591 Million | 568 Million | 52 Million | -2.52 Billion |
Debt repayment | -309 Million | -185 Million | -520 Million | -7 Million | -57 Million | -633 Million |
Dividends payments | -539 Million | -465 Million | -311 Million | -309 Million | -316 Million | -345 Million |
Common Stock Repurchased | -20 Million | -630 Million | 747 Million | - | -25 Million | -1.36 Billion |
Common Stock Issuance | 177 Million | 198 Million | 178 Million | - | 792 Million | - |
Other Financing Activities | -4 Million | -24 Million | -685 Million | 884 Million | -342 Million | -183 Million |
Accounts receivables | -324 Million | -301 Million | -748 Million | 267 Million | -383 Million | -138 Million |
Accounts payables | 253 Million | 50 Million | 241 Million | -533 Million | 4 Million | 88 Million |
Inventory | -87 Million | 2 Million | 135 Million | -117 Million | -16 Million | -12 Million |
Other working capital | -394 Million | -1.02 Billion | 271 Million | -87 Million | -200 Million | -124 Million |
Cash at beginning of period | 2.48 Billion | 2.71 Billion | 1.73 Billion | 1.54 Billion | 2.69 Billion | 4.84 Billion |
Cash at end of period | 1.68 Billion | 2.48 Billion | 2.71 Billion | 1.73 Billion | 1.54 Billion | 2.69 Billion |
Capital Expenditure | -4.1 Billion | -2.72 Billion | -1.74 Billion | -2.19 Billion | -2.82 Billion | -2.09 Billion |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -798 Million | -227 Million | 974 Million | 194 Million | -1.14 Billion | -2.15 Billion |
Free Cash Flow | -166 Million | 1.21 Billion | 1.14 Billion | -864 Million | -1.18 Billion | -158 Million |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 783 Million | 757 Million | 972 Million | 1.38 Billion | 413 Million | 602 Million |
Depreciation & Amortization | 575 Million | 663 Million | 557 Million | 2.19 Billion | 559 Million | 560 Million |
Deferred income taxes | -114 Million | 51 Million | 63 Million | 196 Million | 37 Million | 67 Million |
Stock-based compensation | 20 Million | 20 Million | 39 Million | 87 Million | 18 Million | 16 Million |
Change in working capital | 543 Million | 301 Million | -844 Million | -552 Million | 105 Million | -263 Million |
Other non-cash items | 247 Million | 973 Million | 1.25 Billion | 636 Million | 212 Million | 4 Million |
Investing Cash Flow | -781 Million | -1.3 Billion | -1.1 Billion | -4.66 Billion | -1.59 Billion | -1 Billion |
Investments in PPE | -871 Million | -1.15 Billion | -957 Million | -4.1 Billion | -1.44 Billion | -1 Billion |
Acquisitions | 305 Million | -154 Million | -151 Million | -547 Million | -151 Million | -133 Million |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -215 Million | -1 Million | -1 Million | -8 Million | -3 Million | 135 Million |
Financing Cash Flow | -736 Million | -154 Million | -26 Million | -77 Million | -76 Million | -54 Million |
Debt repayment | -242 Million | -141 Million | -109 Million | -309 Million | -58 Million | -75 Million |
Dividends payments | -154 Million | -134 Million | -137 Million | -539 Million | -134 Million | -134 Million |
Common Stock Repurchased | - | - | - | -20 Million | -72 Million | - |
Common Stock Issuance | -13 Million | 2 Million | 11 Million | 177 Million | -176 Million | 6 Million |
Other Financing Activities | -327 Million | -9 Million | -9 Million | -4 Million | -151 Million | -1 Million |
Accounts receivables | -15 Million | 374 Million | -359 Million | -324 Million | 131 Million | -441 Million |
Accounts payables | 194 Million | 100 Million | -294 Million | 253 Million | 45 Million | 327 Million |
Inventory | 78 Million | - | -78 Million | -87 Million | 29 Million | -55 Million |
Other working capital | 296 Million | -173 Million | -123 Million | -394 Million | -100 Million | -94 Million |
Cash at beginning of period | 2.02 Billion | 1.43 Billion | 1.68 Billion | 2.48 Billion | 2.01 Billion | 2.22 Billion |
Cash at end of period | 1.86 Billion | 2.02 Billion | 1.43 Billion | 1.68 Billion | 1.68 Billion | 2.01 Billion |
Capital Expenditure | -871 Million | -1.15 Billion | -957 Million | -4.1 Billion | -1.44 Billion | -1 Billion |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -161 Million | 587 Million | -250 Million | -798 Million | -330 Million | -208 Million |
Free Cash Flow | 1.18 Billion | 742 Million | -72 Million | -166 Million | -100 Million | -20 Million |
605133
ADXDF
LEG
BNZI
DPT
084695